ClinicalTrials.gg
CompletedNCT03542045Updated Apr 14, 2022

China ATTUNE® Study

An observational study in Osteoarthritis and Post-traumatic Arthritis, sponsored by DePuy Orthopaedics. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-04-14.

Sponsored by DePuy Orthopaedics (part of Johnson & Johnson) · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The study was designed as prospective, single-arm, multi-center which was intended to broadly capture all patients as the technology is adopted.

Read the detailed description

The primary objective is to evaluate the implant survivorship of ATTUNE primary, cemented Knee system in Chinese patients using Kaplan Meier Survivorship at 2 yrs. The subject population is male and female subjects who are candidates for primary, total knee arthroplasty between 18 and 80 years of age, inclusive, willing to consent with indications consistent with the Instructions for Use. A total of 120 subjects will be enrolled in this study.

02

Conditions studied

  • Osteoarthritis
  • Post-traumatic Arthritis

Browse trials for

03

In context

Osteoarthritis

4,445 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 120 is above the median of 100 across 803 observational studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

DePuy Orthopaedics is the lead sponsor of 45 studies on the registry; 2 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 8 (100%) have results posted.

First submitted after DePuy Orthopaedics became part of Johnson & Johnson.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Male and female Subjects who are candidates for primary, total knee arthroplasty between 18 and 80 years of age, inclusive, willing to consent with indications consistent with the Instructions for Use.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Subjects with Subjects with Osteoarthritis (OA), post-trauma arthritis.
  2. Subject is male or female and between the ages of 18 and 80 years old, inclusive.
  3. Subject requires a primary total knee replacement with or without un-resurfaced patella and is considered by the Investigator to be suitable for the specific knee prosthesis identified in the protocol.
  4. Subject requires unilateral knee replacement or the first knee with ATTUNE system during the study will be enrolled for bilateral knee replacement.
  5. Subject, or with the aid of a family member, is able to understand the Informed Consent Document and patient questionnaires.
  6. Subject, with the aid of a family member as needed, has given voluntary, written informed consent to participate in this clinical investigation and has authorized the transfer of his/her information to the Sponsor.
  7. Subject, in the opinion of the Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedures and follow-up visits and co-operate with investigational procedures.

Exclusion criteria

Exclusion Criteria:

  1. The Subject has, in the opinion of the Investigator, an existing condition that would compromise their participation and follow-up in this study, e.g. living in distant areas or having difficulty to return to the site, incooperative to surgeons' medical instructions and suggestions.
  2. The Subject is a woman who is pregnant or lactating.
  3. The Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect follow-up care or treatment outcomes.
  4. The Subject has participated in a clinical investigation with an investigational product in the last 3 months that could impact/affect the outcome of the current procedure and follow-ups judged by the investigator.
  5. The Subject has previous prosthetic knee replacement (any type including unicompartmental, total knee arthroplasty, patellofemoral arthroplasty or ipsilateral Upper Tibial Osteotomy (UTO)/ High Tibial Osteotomy (HTO)) of the affected knee or a previous patellectomy.
  6. Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, cerebral infarction, hemiplegia, Charcot disease, avascular necrosis).
  7. The Subject requires a device not specified in the protocol or the surgeon determines that the ATTUNE Knee System is not a suitable treatment.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (actual)
Target follow-up
2 Years
Patient registry
Yes

Interventions

  • DeviceCemented ATTUNE® Knee System

    This product is for total knee arthroplasty. Four implant configurations are permitted: Cruciate Retaining Fixed Bearing (CR FB), Cruciate Retaining Rotating Platform (CR RP), Posterior Stabilizing Fixed Bearing (PS FB) and Posterior Stabilizing Rotating Platform (PS RP)

06

What researchers measure

Primary outcomes

  1. Implant survivorship.

    To evaluate the implant survivorship of ATTUNE primary, cemented Knee system in Chinese patients using Kaplan Meier Survivorship at 2 yrs.

    Time frame: postoperatively 2 years.

Secondary outcomes

  1. Knee society score (KSS) 2011-surgeon portion at post-operative 2 years compared to pre-op baseline.

    Questionnaire.

    Time frame: pre-operative and post-operative 2 years.

  2. Knee injury and Osteoarthritis Outcome Score (KOOS) at postoperative 2 years compared to pre-op baseline.

    Questionnaire.

    Time frame: Pre-operative baseline and post-operative 2 years.

  3. Euro Quality of life five Dimensions questionnaire five level (EQ5D-5L) at postoperative 2 years compared to pre-op baseline.

    Questionnaire.

    Time frame: Pre-operative and post-operative 2 years.

  4. Knee society score (KSS) 2011-patient portion at post-operative 2 years compared to pre-op baseline.

    Questionnaire.

    Time frame: Pre-operative baseline and post-operative 2 years.

  5. Adverse events and serious adverse events.

    Type and frequency of adverse events and serious adverse events.

    Time frame: Up to post-operative 2 years.

  6. Implant survivorship.

    Kaplan Meier Survivorship at 1 year.

    Time frame: Post-operative 1 year.

  7. Health economy.

    Patient total charges in hospital.

    Time frame: Post-operative 2 years.

  8. Length of hospital stay.

    Hospitalization duration for primary surgery.

    Time frame: Through hospitalization for primary surgery, an average of 2 weeks.

  9. Destination status.

    Home or rehabilitation department/secondary care facility/nursing facility.

    Time frame: At discharge of primary surgery, an average of post-operative 7 days.

Other outcomes

  1. Knee Society Score (KSS) 2011-surgeon portion at post-operative 6 weeks, 6 months and 1 year compared to pre-op baseline.

    Questionnaire.

    Time frame: Pre-operative baseline, post-operative 6 weeks, 6 months, and 1 year.

  2. Knee injury and Osteoarthritis Outcome Score (KOOS) at postoperative 6 weeks, 6 months, 1 year compared to pre-op baseline.

    Questionnaire.

    Time frame: Pre-operative baseline, post-operative 6 weeks, 6 months and 1 year.

  3. Euro Quality of life five Dimensions questionnaire five level (EQ5D-5L) at postoperative 6 weeks, 6 months, 1 year compared to pre-op baseline.

    Questionnaire.

    Time frame: Pre-operative baseline, post-operative 6 weeks, 6 months and 1 year.

  4. Knee society score (KSS) 2011-patient portion at post-operative 6 weeks, 6 months, 1 year compared to pre-op baseline.

    Questionnaire.

    Time frame: Pre-operative baseline, post-operative 6 weeks, 6 months and 1 year.

  5. Radiographic evaluation.

    Radiographic evaluation at immediate post operation and 6 weeks, 1 year visit.

    Time frame: Immediate post operation, post-operative 6 weeks and 1 year.

07

Study locations

1 site
  • Yantaishan Hospital
    Yantai, Shangdong 264001, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03542045
Lead sponsor
DePuy Orthopaedics
Responsible party
Sponsor
First posted
May 31, 2018
Start date
Apr 12, 2018
Primary completion
Nov 19, 2021
Completion
Nov 19, 2021
Last update
Apr 14, 2022

Study contacts

Shudong Zhang
principal investigator · Yantaishan Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion